LCP

Lamond Capital Partners Portfolio holdings

AUM $14.3M
1-Year Est. Return 19.1%
This Quarter Est. Return
1 Year Est. Return
-19.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.3M
AUM Growth
-$52.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$18.3M
2
+$17.3M
3
+$12.2M
4
ABBV icon
AbbVie
ABBV
+$2.86M
5
RXDX
Ignyta, Inc.
RXDX
+$626K

Sector Composition

1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$385B
$14.3M 100%
250,000
-50,000
AMGN icon
2
Amgen
AMGN
$172B
– –
-75,000
ORCL icon
3
Oracle
ORCL
$669B
– –
-500,000
PBYI icon
4
Puma Biotechnology
PBYI
$288M
– –
-220,780
IMMU
5
DELISTED
Immunomedics Inc
IMMU
– –
-100,000
RXDX
6
DELISTED
Ignyta, Inc.
RXDX
– –
-46,721
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-16,119